Public-private partnerships (PPPs)

Public-private partnerships are seen as an effective way to capitalize on the relative strengths of the public and private sectors to address problems that neither could tackle adequately on its own, in particular in respect of diseases that particularly affect developing countries where research by the private sector is deemed insufficient. Thus the public sector contributes both basic science and funding, and the private sector has strengths in drug discovery and bringing candidate drugs through the trials process to regulatory approval. The lack of incentive is addressed by creating a PPP entity with a well-defined objective relating to the development of a particular product or technology required by developing countries.